Quick Takeaways
- FLNA - FILANA THERAPEUTICS, INC. has 16 insiders with reported activity on this page.
- Net insider value flow over the last year: +$1,231,784.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 16 Insiders of FILANA THERAPEUTICS, INC.
- Symbol
- FLNA on Nasdaq
- Location
- Austin, TX
What Changed
- Buy value: $1,231,784; sell value: $0.
- Net share flow: +490,823.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$1,231,784.
Buys
$1,231,784
Shares: 490,823
Insiders: 3
Sells
$0
Shares: 0
Insiders: 0
Net
+$1,231,784
Shares: +490,823
Insiders: 3
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 231,985 | 0 | $640,749 | $0 | +$640,749 |
| 6-9 | 258,838 | 0 | $591,035 | $0 | +$591,035 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
FILANA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sanford Robertson | Director | $25,241,772 | Mixed | 16 May 2024 | ||
| Richard Barry | President & CEO, Director | $12,711,045 | +$1,166,904 | +10% | Mixed | 20 Nov 2025 |
| Robert Christopher Cook | Chief Operating & Legal Office | $1,726,939 | +$39,940 | +2.4% | Mixed | 30 Sep 2025 |
| Freda Nassif | Chief Business Officer | $1,687,000 | Mixed | 17 Apr 2025 | ||
| James William Kupiec | Chief Medical Officer | $1,687,000 | Mixed | 29 Nov 2024 | ||
| Jaren Landen | Chief Clinical Dev. Officer | $1,433,950 | Mixed | 18 Nov 2024 | ||
| Remi Barbier | President & CEO, Director | $843,500 | Mixed | 20 May 2024 | ||
| Robert Z. Gussin | Director | $253,050 | Mixed | 23 May 2025 | ||
| Robert Eugene Anderson Jr. | Director | $193,640 | +$24,940 | +15% | Mixed | 24 Nov 2025 |
| Michael J. O Donnell | Director | $168,700 | Mixed | 23 May 2025 | ||
| Pierre Gravier | Director | $168,700 | Mixed | 23 May 2025 | ||
| Claude Nicaise | Director | $168,700 | Mixed | 23 May 2025 | ||
| Patrick J. MD Scannon PhD | Director | $168,700 | Mixed | 23 May 2025 | ||
| Eric J. Schoen | Chief Financial Officer | $44,390 | Filing P/S | 17 Apr 2025 | ||
| Nadav Friedmann | Chief Medical Officer, Director | $2,495 | Mixed | 31 Dec 2022 | ||
| Dawn Carter Bir | Director | Mixed | 21 Oct 2025 |
Top shareholders of FILANA THERAPEUTICS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sanford Robertson |
3/4/5
|
Director |
—
mixed-class rows
|
1,531,591
mixed-class rows
|
$25,241,772 | — | 16 May 2024 | |
| Richard Barry |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
1,288,060
mixed-class rows
|
$12,711,045 | +$1,166,904 | 20 Nov 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
4.5%
from 13D/G
|
2,375,589
|
$4,703,666 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
4.4%
|
2,115,307
|
$4,188,307 | — | 31 Dec 2025 | |
| Nachtrab Matthew |
13D/G
|
— |
4.7%
|
2,267,636
|
$3,560,189 | $0 | 16 Aug 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
3.2%
from 13D/G
|
1,419,934
|
$2,811,469 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2%
|
954,800
|
$1,890,504 | — | 31 Dec 2025 | |
| Robert Christopher Cook |
3/4/5
|
Chief Operating & Legal Office |
—
mixed-class rows
|
113,725
mixed-class rows
|
$1,726,939 | +$39,940 | 30 Sep 2025 | |
| Freda Nassif |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
100,000
|
$1,687,000 | — | 17 Apr 2025 | |
| James William Kupiec |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
100,000
|
$1,687,000 | — | 29 Nov 2024 | |
| Jaren Landen |
3/4/5
|
Chief Clinical Dev. Officer |
—
class O/S missing
|
85,000
|
$1,433,950 | — | 18 Nov 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.3%
|
642,401
|
$1,271,954 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
545,969
|
$1,081,433 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.1%
|
528,018
|
$1,045,476 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.1%
|
513,137
|
$1,016,011 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.97%
|
469,326
|
$929,266 | — | 31 Dec 2025 | |
| Remi Barbier |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
50,000
|
$843,500 | — | 20 May 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.62%
|
299,579
|
$593,166 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.6%
|
287,879
|
$570,000 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.59%
|
284,213
|
$561,000 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
274,399
|
$543,310 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.56%
|
269,470
|
$533,551 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.51%
|
246,987
|
$489,034 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
212,187
|
$420,130 | — | 31 Dec 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.43%
|
206,835
|
$409,533 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.36%
|
173,065
|
$342,668 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
149,194
|
$295,405 | — | 31 Dec 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.3%
|
144,100
|
$285,318 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.29%
|
140,057
|
$277,313 | — | 31 Dec 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.27%
|
128,703
|
$254,832 | — | 31 Dec 2025 | |
| Robert Z. Gussin |
3/4/5
|
Director |
—
class O/S missing
|
26,500
|
$253,050 | — | 23 May 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.21%
|
100,577
|
$199,142 | — | 31 Dec 2025 | |
| Robert Eugene Anderson Jr. |
3/4/5
|
Director |
—
mixed-class rows
|
35,100
mixed-class rows
|
$193,640 | +$24,940 | 24 Nov 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.19%
|
91,620
|
$181,408 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.19%
|
91,479
|
$181,128 | — | 31 Dec 2025 | |
| Claude Nicaise |
3/4/5
|
Director |
—
class O/S missing
|
26,500
|
$168,700 | — | 23 May 2025 | |
| Michael J. O Donnell |
3/4/5
|
Director |
—
class O/S missing
|
26,500
|
$168,700 | — | 23 May 2025 | |
| Patrick J. MD Scannon PhD |
3/4/5
|
Director |
—
class O/S missing
|
26,500
|
$168,700 | — | 23 May 2025 | |
| Pierre Gravier |
3/4/5
|
Director |
—
class O/S missing
|
26,500
|
$168,700 | — | 23 May 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.17%
|
83,900
|
$166,122 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
70,439
|
$139,471 | — | 31 Dec 2025 | |
| Gallacher Capital Management LLC |
13F
|
Company |
0.13%
|
64,975
|
$128,650 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.11%
|
53,367
|
$105,667 | — | 31 Dec 2025 | |
| Headlands Technologies LLC |
13F
|
Company |
0.11%
|
50,866
|
$100,715 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.1%
|
48,832
|
$97,000 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
48,462
|
$95,955 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.09%
|
43,427
|
$85,985 | — | 31 Dec 2025 | |
| Apollon Wealth Management, LLC |
13F
|
Company |
0.08%
|
39,538
|
$78,285 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
34,928
|
$69,157 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
32,989
|
$65,318 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for FILANA THERAPEUTICS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Robert Eugene Anderson Jr. | SAVA | Common Stock | Purchase | $24,940 | $2.90 | 8,600 | 8,600 | 24 Nov 2025 | Direct | |
| Richard Barry | SAVA | Common Stock | Purchase | 19% | $414,000 | $2.76 | 150,000 | 938,060 | 20 Nov 2025 | By Trust |
| Richard Barry | SAVA | Common Stock | Purchase | 10.3% | $201,809 | $2.75 | 73,385 | 788,060 | 19 Nov 2025 | By Trust |
| Dawn Carter Bir | SAVA | Stock Option (Right to Buy) | Award | 53,000 | 53,000 | 21 Oct 2025 | Direct | |||
| Robert Christopher Cook | SAVA | Common Stock | Purchase | $39,940 | $2.91 | 13,725 | 13,725 | 30 Sep 2025 | Direct | |
| Richard Barry | SAVA | Common Stock | Purchase | 1.01% | $16,352 | $2.28 | 7,172 | 714,675 | 22 Sep 2025 | By Trust |
| Richard Barry | SAVA | Common Stock | Purchase | 7.17% | $108,319 | $2.29 | 47,308 | 707,503 | 19 Sep 2025 | By Trust |
| Richard Barry | SAVA | Common Stock | Purchase | 40.6% | $426,424 | $2.24 | 190,633 | 660,195 | 18 Sep 2025 | By Trust |
| Patrick J. MD Scannon PhD | SAVA | Stock Option (Right to Buy) | Award | 26,500 | 26,500 | 23 May 2025 | Direct | |||
| Robert Eugene Anderson Jr. | SAVA | Stock Option (Right to Buy) | Award | 26,500 | 26,500 | 23 May 2025 | Direct | |||
| Pierre Gravier | SAVA | Stock Option (Right to Buy) | Award | 26,500 | 26,500 | 23 May 2025 | Direct | |||
| Robert Z. Gussin | SAVA | Stock Option (Right to Buy) | Award | 26,500 | 26,500 | 23 May 2025 | Direct | |||
| Claude Nicaise | SAVA | Stock Option (Right to Buy) | Award | 26,500 | 26,500 | 23 May 2025 | Direct | |||
| Michael J. O Donnell | SAVA | Stock Option (Right to Buy) | Award | 26,500 | 26,500 | 23 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.